The Mix Tape
In part 2 of our Special Edition Series - Cell and Gene Tx Journey to Commercialization - Abbey Jenkins (CEO, Gamida Cell) and Izzy Tyszler (VP of Commercial, Zevra Therapeutics) join ADVI Health’s Director of Health Policy and Reimbursement, Alicia Silver, to discuss commercialization of gene and cell therapies. Abbey and Izzy share their key learnings from past experiences, advice on how best to prepare for commercialization, and leading commercial teams. This 2-part special edition, is brought to you by Mix Talent [https://www.linkedin.com/company/mix-talent/] and ADVI Health [https://www.linkedin.com/company/advi/] to bring together women leaders in Cell and Gene Therapy to discuss the journey from manufacturing to commercialization.
37 Folgen
Kommentare
0Sei die erste Person, die kommentiert
Melde dich jetzt an und werde Teil der The Mix Tape-Community!